Indian Oil Corporation reported a 50 per cent jump in its March quarter net profit as inventory gains negated losses on sale of subsidised domestic cooking gas LPG.

Xanamem is an investigational product and is not approved for use outside of a clinical trial by the FDA or by any global regulatory authority. Xanamem ® is a trademark of Actinogen Medical.

As many as 22 important names like Vedanta, Indian Oil Corporation, Adani Power, Aeroflex Industries, Ajanta Pharma, Bandhan ...

Q3 2025 Earnings Call Transcript April 29, 2025 Brinker International, Inc. beats earnings expectations. Reported EPS is ...

While the fourth quarter EBITDA dipped 5% to ₹235 crore, margins remained healthy at 27.1%. FY25 EBITDA grew 8% to ₹975 crore ...

Q4 2025 Earnings Call Transcript April 29, 2025 Commvault Systems, Inc. beats earnings expectations. Reported EPS is $1.03, ...

JSW Infra, the second-largest private commercial port operator, also reported a 17.06 per cent rise in revenue from ...

Federal Bank's profit for the quarter came at Rs 1030 crore compared with Rs 906 crore in the same quarter last year. Net ...

Adani Green Energy announced its Q4 results FY25 and posted over $1 billion in EBITDA in FY25, driven by a record ₹9,495 ...

The company's all-India power demand grew by 3.5% to 415 BU in Q4 FY25 compared to Q4 FY24. The full-year power demand grew ...

Supernus' reliance on Qelbree is increasing, but generic competition for other drugs poses challenges. Read why I downgrade ...

Adani Power posted Q4 profit at Rs 2,636.97 crore, down 3.66 per cent in comparison to Rs 2,737.24 crore recorded during the corresponding quarter of FY24.